Hemoptysis in patients with non-Eisenmenger pulmonary arterial hypertension (PAH)– management and prognostic significance Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012
Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
RV/TLC ratio as an independent prognostic indicator in idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
Clinical outcomes of pulmonary arterial hypertension in carriers of ACVRL1 (ALK1 ) mutation Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009
Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012
Cure pulmonary arterial hypertension associated with HIV (PAH-HIV)? … Toward an answer Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker? Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Vascular effects of CPAP – Therapy in patients with arterial hypertension and severe OSA Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010
Everolimus improves exercise capacity and pulmonary vascular resistance in patients with advanced pulmonary hypertension – A pilot study Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008
Prognostic value of hemodynamics following treatment initiation in pulmonary arterial hypertension Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension Year: 2017
Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011
Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009
Predicting survival in pulmonary arterial hypertension in the UK}, Source: Eur Respir J 2012; 40: 604-611 Year: 2012
The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002